Prospective Randomized Trial of Direct Endomyocardial Implantation of Bone Marrow Cells for Therapeutic Angiogenesis in Coronary Artery Diseases - PROTECT-CAD

Description:

The goal of the trial was to evaluate treatment with bone marrow mononuclear cells (BM MNC) among patients with severe coronary artery disease who have failed conventional therapies.